Status:

COMPLETED

Tryptophan Metabolism in Kidney Disease

Lead Sponsor:

Charite University, Berlin, Germany

Conditions:

Chronic Kidney Disease

Eligibility:

All Genders

18-90 years

Brief Summary

Tryptophan metabolism in kidney disease will be investigated in patients with chronic kidney disease stages (ADOQI 3-5). Tryptophan levels and respective catabolites will be assessed under hemodialysi...

Eligibility Criteria

Inclusion

  • Chronic kidney disease (for \> 3months) stages (National Kidney foundation/ADOQI): 3-5

Exclusion

  • Signs of infection or systemic inflammation

Key Trial Info

Start Date :

January 1 2007

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

October 1 2008

Estimated Enrollment :

80 Patients enrolled

Trial Details

Trial ID

NCT00758537

Start Date

January 1 2007

End Date

October 1 2008

Last Update

July 14 2009

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Charite University Medicine Berlin

Berlin, State of Berlin, Germany, 13353

Tryptophan Metabolism in Kidney Disease | DecenTrialz